Genetics Modifiers of Anthrax Lethal Toxin Induced Pathophysiology

炭疽致死毒素诱导病理生理学的遗传学修饰

基本信息

项目摘要

Virulence of Bacillus anthracis is associated with the secretion of three plasmid-encoded toxin proteins: protective antigen (PA), lethal factor (LF), and edema factor (EF). LF and EF are catalytic moieties that share the receptor-binding subunit, PA. As a result, two binary toxins are formed: lethal toxin (LT) consisting of PA and Injection of purified LT into animals induces many of the pathologies associated with fulminate anthrax infection indicating that this toxin plays a significant role in disease. However, there is a lack of consensus about how LT causes these pathologies. In response to LT injection, a rapidly induced phenotype was identified in a congenic strain of mice that has a chromosomal segment of the CAST/EiJ strain on an otherwise C57BL/6J background. Our evidence indicates that the genetic factor(s) accounting for this early response also plays role in resistance to spore challenge establishing the significance of this phenotype. We propose to study the early phenotype of advance the understanding of early phathophysiolgical mechanisms and to reveal genetic factors that influence the presentation of LT induced disease well as resistance to spores. First, the qualitative trait loci (QTL) controlling early sensitivity will be mapped by complimentary approaches (i.e., positional cloning and expression QTL analysis). Second, the pathophysiological mechanism driving the early phenotype will be determined by studies that include intravital microscopy and pharmacological approaches. In summary, the early responding congenic strain will be a powerful tool for: 1) identifying genetic factors that regulate sensitivity to LT, 2) elucidating the pathophysiological mechanisms associated with early LT-induced events, and 3) revealing defense mechanisms that are employed by the host in response to LT or spore challenge.
炭疽杆菌的毒力与三种质粒编码的毒素蛋白的分泌有关:保护性抗原(PA)、致死因子(LF)和水肿因子(EF)。LF和EF是共享受体结合亚基PA的催化部分。结果,形成两种二元毒素:由PA和PA组成的致死毒素(LT)。 将纯化的LT注射到动物中诱导许多与暴发性炭疽感染相关的病理,表明该毒素在疾病中起重要作用。然而,对于LT如何导致这些病理缺乏共识。在对LT注射的响应中,在具有CAST/EiJ品系的染色体片段的同类系小鼠中鉴定出快速诱导的表型,所述染色体片段在另外的C57 BL/6 J背景上。我们的证据表明,解释这种早期反应的遗传因素也在对孢子挑战的抗性中起作用,从而确定了这种表型的意义。我们建议研究早期表型,以促进对早期phathophysiological机制的理解,并揭示影响LT诱导的疾病的呈现以及对孢子的抗性的遗传因素。 首先,控制早期敏感性的质量性状基因座(QTL)将通过互补方法(即,定位克隆和表达QTL分析)。 其次,驱动早期表型的病理生理机制将通过包括活体显微镜和药理学方法的研究来确定。 总之,早期反应的同类菌株将是一个强大的工具:1)确定遗传因素,调节LT的敏感性,2)阐明与早期LT诱导的事件相关的病理生理机制,和3)揭示防御机制,由主机在响应LT或孢子的挑战。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kenneth Alan Bradley其他文献

Kenneth Alan Bradley的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kenneth Alan Bradley', 18)}}的其他基金

Cellular Intoxication Pathway of Cytolethal Distending Toxin
细胞致死膨胀毒素的细胞中毒途径
  • 批准号:
    8322033
  • 财政年份:
    2011
  • 资助金额:
    $ 38.95万
  • 项目类别:
Cellular Intoxication Pathway of Cytolethal Distending Toxin
细胞致死膨胀毒素的细胞中毒途径
  • 批准号:
    8163122
  • 财政年份:
    2011
  • 资助金额:
    $ 38.95万
  • 项目类别:
Cellular Intoxication Pathway of Cytolethal Distending Toxin
细胞致死膨胀毒素的细胞中毒途径
  • 批准号:
    8730187
  • 财政年份:
    2011
  • 资助金额:
    $ 38.95万
  • 项目类别:
Cellular Intoxication Pathway of Cytolethal Distending Toxin
细胞致死膨胀毒素的细胞中毒途径
  • 批准号:
    8607690
  • 财政年份:
    2011
  • 资助金额:
    $ 38.95万
  • 项目类别:
Cellular Intoxication Pathway of Cytolethal Distending Toxin
细胞致死膨胀毒素的细胞中毒途径
  • 批准号:
    8536865
  • 财政年份:
    2011
  • 资助金额:
    $ 38.95万
  • 项目类别:
Retrocyclins: Cyclic mini-defensins that inactivate anthrax toxins
逆转录素:可灭活炭疽毒素的环状迷你防御素
  • 批准号:
    7463962
  • 财政年份:
    2009
  • 资助金额:
    $ 38.95万
  • 项目类别:
Molecular Screening Shared Resouce
分子筛选共享资源
  • 批准号:
    7944609
  • 财政年份:
    2009
  • 资助金额:
    $ 38.95万
  • 项目类别:
Genetics Modifiers of Anthrax Lethal Toxin Induced Pathophysiology
炭疽致死毒素诱导病理生理学的遗传学修饰
  • 批准号:
    7895640
  • 财政年份:
    2009
  • 资助金额:
    $ 38.95万
  • 项目类别:
Retrocyclins: Cyclic mini-defensins that inactivate anthrax toxins
逆转录素:可灭活炭疽毒素的环状迷你防御素
  • 批准号:
    7897621
  • 财政年份:
    2009
  • 资助金额:
    $ 38.95万
  • 项目类别:
Genetics Modifiers of Anthrax Lethal Toxin Induced Pathophysiology
炭疽致死毒素诱导病理生理学的遗传学修饰
  • 批准号:
    7690580
  • 财政年份:
    2008
  • 资助金额:
    $ 38.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 38.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了